CXHB2200130 | 吸入用TQC3721混悬液 | TQC-3721 | Suspension | Chemical Drugs(1) | Supplementary Application | 2022-08-15 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
CXHB2200131 | 吸入用TQC3721混悬液 | TQC-3721 | Suspension | Chemical Drugs(1) | Supplementary Application | 2022-08-15 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
CXHB2500077 | 吸入用TQC3721混悬液 | TQC-3721 | Suspension | Chemical Drugs(1) | Supplementary Application | 2025-03-27 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
CXHB2500078 | 吸入用TQC3721混悬液 | TQC-3721 | Suspension | Chemical Drugs(1) | Supplementary Application | 2025-03-27 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
CXHL2100006 | 吸入用TQC3721混悬液 | TQC-3721 | Suspension | Chemical Drugs(1) | New Drug Application | 2021-01-08 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | In Review | 2021-01-07 | view |